Sipai Health Technology Co., Ltd. (HKG:0314)
Hong Kong · Delayed Price · Currency is HKD 2.230
+0.020 (0.90%)
At close: Feb 13, 2026
Sipai Health Technology Revenue
Sipai Health Technology had revenue of 1.22B CNY in the half year ending June 30, 2025, a decrease of -49.79%. This brings the company's revenue in the last twelve months to 3.43B, down -26.14% year-over-year. In the year 2024, Sipai Health Technology had annual revenue of 4.57B, down -3.11%.
Revenue (ttm)
3.43B CNY
Revenue Growth
-26.14%
P/S Ratio
0.44
Revenue / Employee
1.16M CNY
Employees
2,950
Market Cap
1.65B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.57B | -146.67M | -3.11% |
| Dec 31, 2023 | 4.71B | 592.63M | 14.39% |
| Dec 31, 2022 | 4.12B | 645.55M | 18.58% |
| Dec 31, 2021 | 3.47B | 774.28M | 28.68% |
| Dec 31, 2020 | 2.70B | 1.66B | 159.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sinopharm Group | 626.85B |
| Charmacy Pharmaceutical | 4.65B |
| ETHK Labs | 3.37B |
| Sinco Pharmaceuticals Holdings | 2.73B |
| ClouDr Group | 2.47B |
| 160 Health International | 698.59M |
| Ziyuanyuan Holdings Group | 575.61M |
| Wanjia Group Holdings | 163.70M |